Comparing angiotensin receptor–neprilysin inhibitors with sodium–glucose cotransporter 2 inhibitors for heart failure with diabetes mellitus

BACKGROUND AND AIMS: Clinical comparisons of angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) treatment in patients with HFrEF and T2DM are limited. This study evaluated the clinical outcomes and treatment benefits of SGLT2i versus ARNI treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsai, Ming-Lung, Lin, Yuan, Lin, Ming-Shyan, Tsai, Tzu-Hsien, Yang, Ning-I, Wang, Chao-Yung, Hsieh, I-Chang, Hung, Ming-Jui, Chen, Tien-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214563/
https://www.ncbi.nlm.nih.gov/pubmed/37237322
http://dx.doi.org/10.1186/s13098-023-01081-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214563/
https://www.ncbi.nlm.nih.gov/pubmed/37237322
http://dx.doi.org/10.1186/s13098-023-01081-2

Ejemplares similares